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MraY translocaseNanodiscs (NDs) enable the analysis of membrane proteins (MP) in natural lipid bilayer environments. In
combination with cell-free (CF) expression, they could be used for the co-translational insertion of MPs
into deﬁned membranes. This new approach allows the characterization of MPs without detergent contact
and it could help to identify effects of particular lipids on catalytic activities. Association of MPs with different
ND types, quality of the resulting MP/ND complexes as well as optimization parameters are still poorly ana-
lyzed. This study describes procedures to systematically improve CF expression protocols for the production
of high quality MP/ND complexes. In order to reveal target dependent variations, the co-translational ND
complex formation with the bacterial proton pump proteorhodopsin (PR), with the small multidrug resis-
tance transporters SugE and EmrE, as well as with the Escherichia coliMraY translocase was studied. Parameters
which modulate the efﬁciency of MP/ND complex formation have been identiﬁed and in particular effects of
different lipid compositions of the ND membranes have been analyzed. Recorded force distance pattern as
well as characteristic photocycle dynamics indicated the integration of functionally folded PR into NDs. Efﬁcient
complex formation of the E. coliMraY translocase was dependent on the ND size and on the lipid composition of
the NDmembranes. Active MraY protein could only be obtained with ND containing anionic lipids, thus provid-
ing new details for the in vitro analysis of this pharmaceutically important protein.
© 2012 Elsevier B.V. All rights reserved.BR, bacteriorhodopsin; Cd,
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The production of membrane proteins (MPs) by cell-free (CF)
expression has emerged as alternative option to conventional in
vivo expression systems [1]. CF systems based on Escherichia coli
extracts are in particular high in productivity, robust and relatively
fast to establish [2]. The open nature of CF systems allows providing
artiﬁcial environments composed of detergents, liposomes or other
hydrophobic compounds including amphipols [3] and ﬂuorinated
surfactants [4] that could be adjusted to speciﬁc requirements of the
synthesized MP [5–7]. However, supplied preformed liposomes
often tend to rearrange and to precipitate during the expression reac-
tion resulting in high sample heterogeneity [8–13]. Alternatively,
nanodiscs (NDs) based on lipo-protein particles formed by mem-
brane scaffold proteins (MSP) provide stable membranes of deﬁned
sizes [14]. ND membranes can be individually designed thus allowing
to study effects of the lipid environment on the membrane insertion,
stability and function of MPs.
3099C. Roos et al. / Biochimica et Biophysica Acta 1818 (2012) 3098–3106The co-translational association of CF expressed MPs with supplied
NDs resulted into soluble and ligand binding active complexes with
G-protein coupled receptors [15,16] and into functional bacteriorho-
dopsin [17]. However, the efﬁcient formation of high quality MP/ND
complexes depends on multiple parameters. In particular effects of ND
size, ND concentration and membrane composition on the solubiliza-
tion efﬁciency and on the activity of MPs have hardly been studied.
We have evaluated the co-translational complex formation of integral
MPs with two types of NDs assembled with membranes containing dif-
ferent lipid compositions. The ND complex formation with the four
transmembrane segment (TMS) containing multidrug transporters
EmrE and SugE, with the ten TMS containing phospho-N-acetyl-
muramoyl-pentapeptide translocase MraY of E. coli and with the
seven TMS containing proton pump proteorhodopsin (PR) has been
analyzed.
Modulation of the co-translational MP/ND complex formation has
been monitored by using MP fusions with shifted green ﬂuorescent
protein (sGFP). The quality of generated PR/ND complexes was stud-
ied by single-molecule force spectroscopy (SMFS) and ﬂash photoly-
sis. The recorded force pattern as well as the characteristic
photocycle dynamics indicated the correct folding of the membrane
inserted PR. We further demonstrate the effects of membrane compo-
sition on MP/ND complex formation and we show for the ﬁrst time
that the functional folding of the E. coli MraY translocase responsible
for lipid I formation in bacterial cell-wall biosynthesis is dependent
on the presence of anionic phospho-glycerol lipids.
2. Materials and methods
2.1. Lipids and detergents
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dimyristoyl-sn-glycero-3-phospho-(1′-rac-
glycerol) (DMPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-
glycerol) (POPG), 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
(DOPG), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE),
E. coli polar lipid extract (PLE. coli), E. coli total lipid extract (TLE. coli), 1-
palmitoyl-2-(12-[(7-nitro-2-1, 3-benzoxadiazol-4-yl)amino]dodecanoyl)-
sn-glycero-3-phosphocholine (PC-NBD) and 1′,3′-bis[1,2-dimyristoyl-sn-
glycero-3-phospho]-sn-glycerol (Cardiolipin, Cd 14:0) were purchased
from Avanti Polar Lipids (Alabaster, USA). Na+-cholate was purchased
from Roth (Karlsruhe, Germany), dodecyl-phosphocholine (DPC) from
Anatrace (High Wycombe, UK) and 1,2-diheptanoyl-sn-glycero-3-
phosphocholine (DHPC) from Avanti Polar Lipids (Alabaster, USA).
2.2. Cell-free expression
DNA templates for CF expression are summarized in Table A1
(Supplementary data). Expression vectors pET21a(+), pET22 and
pET28 (Merck, Darmstadt, Germany) and pIVEX2.3d (Roche Applied
Science, Mannheim, Germany) were used. If C-terminal StrepII-tag
were required, overlap PCR with the StrepII-tag coding sequence
(5′-TGGAGCCACCCGCAGTTCGAAAAA-3′, Biospring, Frankfurt, Ger-
many) was performed. Plasmid template DNAwas puriﬁed with stan-
dard kits (NucleoBond®, Macherey‐Nagel, Düren, Germany).
T7-RNA polymerase preparation and continuous-exchange cell-free
(CECF) expression were performed using the standard protocol as de-
scribed elsewhere [2]. Amino acid mixtures were prepared as 25 mM
stock and potassium acetate in 10 M stock. Analytical scale reaction
volumes were 55 μl with a ratio of reaction mixture (RM) to feeding
mixture (FM) of 1 to 17. The reactions were incubated in Mini-CECF re-
actors [18] in 24well plates (Greiner, Frickenhausen, Germany) holding
the FM. Each target was optimized with regard toMg2+-ion concentra-
tion in the absence of NDs. Best expression yields were achieved with
Mg2+ concentrations of 14 mM for SugE-sGFP, 18 mM for MraY,MraY-sGFP, EmrE and EmrE-sGFP and 20 mM for PR. NDs were applied
into the RM only in concentrations of up to 150 μM. Soluble fractions
were removed from the RM after the expression experiment by centri-
fugation (22,000×g, 10 min).
PR for post-translational ND complex formation was expressed as
described before [19]. During puriﬁcation, detergent was adjusted to
0.1% (w/v) DHPC in Strep-binding and ‐elution buffer (see below).
Concentration of the puriﬁed protein was determined using a
NanoDrop (Peqlab, Erlangen, Germany) with MW=30.5 kDa and
A280 ε=80,510 M−1 cm−1.
2.3. Protein analysis
For SDS polyacrylamide gel electrophoresis (SDS-PAGE) 4 μl 5×
loading buffer (60 mM Tris-HCl, 1.5% (w/v) SDS, 3% (w/v) glycerol, 5%
(w/v) β-mercaptoethanol, 0.02% (w/v) bromophenol blue, pH 6.8)
were added to 16 μl of sample and incubated at +37 °C for 10 min. CF
pellets were ﬁrst resuspended in 55 μl S30-buffer (10 mM Tris-
acetate, 14 mM Mg(OAc)2, 60 mMKCl, pH 8.2). Sampleswere separated
on 11% (w/v) Tris/Tricine/SDS gel and either stained with Coomassie
blue or used for immunoblotting.
For StrepII-tag puriﬁcation, samples were diluted 5 times in
Strep-binding buffer (20 mM Tris-HCl, 100 mM NaCl, pH 7.5) and in-
cubated with equilibrated StrepII-Tactin resin (IBA, Goettingen,
Germany) depending on the amount of protein (in general for 1 ml
RM, 500 μl resin was used). Binding was achieved by overnight incu-
bation on a rotary device at +4 °C. Unbound protein was removed
with 5 column volumes Strep-binding buffer. Elution was achieved
in one fraction of 0.5 column volumes and four fractions of 1 column
volume with Strep-elution buffer (20 mM Tris-HCl, 100 mM NaCl,
5 mM desthiobiotin, pH 7.5).
For size exclusion chromatography (SEC), samples were centrifuged
(22,000×g, 10 min) to remove aggregates before loading on a Superdex
200 3.2/30, or a Tricon 10/300 with Superdex 200 resin (GE Healthcare,
Muenchen, Germany). Elution of ND complexes were monitored via
A280 and additionally at A530 when PR was included or A464 when
sGFP-fusions were used.
2.4. MSP expression and preparation of empty nanodiscs
MSP1 and MSP1E3D1 were expressed with an N-terminal His6-tag
followed by the TEV protease cleavage site without any linker regions
(MGSSHHHHHHENLYFQG-MSP) [14]. The MSP1 construct contains
the full-length ﬁrst helix of the membrane scaffold protein, whereas
the ﬁrst helix is truncated (Δ1-11, indicated by D1) in the elongat-
ed construct (MSP1E3D1). The His-tags were not removed from
the MSPs after puriﬁcation. Concentrations were determined by
A280 ε=24,750 M−1 cm−1 (MSP1) or A280 ε=27,310 M−1 cm−1
(MSP1E3D1) with the molecular weight of MW=25.3 kDa (MSP1) or
MW=31.96 kDa (MSP1E3D1), respectively, using a NanoDrop device
(Peqlab, Erlangen, Germany). Stocks of puriﬁed MSPs were stored at
−80 °C and thawed on ice before usage.
Chloroform solubilized lipids were applied to a rotary evaporator
(Rotavapor RE120, Büchi, Essen, Germany) to remove chloroform.
Each lipid was resuspended in water at ﬁnal concentrations of
50 mM and solubilized with Na+-cholate supported by vortexing or
incubating at +37 °C in an ultrasonic water bath. Solubilization was
complete when the suspension turned clear. Required Na+-cholate
concentrations for complete solubility were 100 mM for DMPC,
200 mM for POPC, POPG, DOPG and PLE. coli, 300 mM for DOPC,
DMPG and DOPE and 500 mM for TLE. coli. Lipids were ﬁltered (pore
size 0.45 μm), stocks were stored at−20 °C and thawed on ice before
usage.
MSP was combined with the selected lipids at a deﬁned molar stoi-
chiometry (Table A2, Supplementary data). For some experiments, NDs
were supplemented with 1% phosphocholine lipid labeled with the
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Alabaster, USA) [20], by combining PC-NBD with e.g. DMPC prior to
ND assembling. The speciﬁc ﬂuorescence of PC-NBD could then be
used to monitor ND solubility. The mixtures of MSP (25 μM), lipid and
DPC (0.1%w/v)were incubated at room temperature for 1 h. ND forma-
tion was initialized by dialysis against 5 l of dialysis buffer (40 mM
Tris-HCl, 100 mM NaCl, pH 8.0). The ﬁrst dialysis was performed at
room temperature for 16 h followed by buffer exchange and further di-
alysis at+4 °C for additional 16 h. This step was repeated twice. Deter-
gent removal by Biobeads did result in less homogeneous ND
preparations with high variation in reproducibility. After dialysis, NDs
were centrifuged (22,000×g, 20 min) to remove residual aggregates
and stored on ice before concentrating.
The supernatant of ND assemblies were applied to Centriprep con-
centrator devices (10 kDa MWCO, Millipore, Merck, Darmstadt, Ger-
many) equilibrated with at least 3 ml of dialysis buffer. Centripreps
were centrifuged at +4 °C and 2000×g and NDs were concentrated
up to ﬁnal MSP concentrations of 2.4 mM, equivalent to ND concen-
trations of 1.2 mM. ND stocks were centrifuged (22,000×g, 20 min)
and stored on ice before usage. For long time storage, NDs were
ﬂash frozen in liquid nitrogen and stored at−80 °C.
2.5. Post-translational PR/ND complex formation
Puriﬁed PR in DHPC was mixed with MSP1 and DMPC lipids (PR to
MSP1 to DMPC ratio of 1:2:40) and incubated at room temperature
for 1 h. Assembly of NDs was induced by dialysis as described above.
2.6. MraY functional assay
MraY/ND complexes for speciﬁc activity calculation were quanti-
ﬁed by immunodetection after Western blotting with protein-
standards for concentration estimation (Precision Plus Protein
Unstained standards, Bio-Rad, Muenchen, Germany). Densitometric
analysis of band intensities was performed using the software ImageJ.
As reference, the 50 kDa marker band was set at 100 μg/ml as
recommended by the supplier. Averages of triplicates from linear
range measurements were used for calculation. The functional analy-
sis of MraY-(sGFP)/ND complexes was performed as described else-
where [7].
2.7. sGFP assay
Fluorescence signal of the sGFP fusion was measured as described
elsewhere [21]. CF pellets were suspended in 55 μl S30-buffer and
supernatants were measured directly.
2.8. Single-molecule force spectroscopy (SMFS)
Unfolding of MPs out of NDs were carried out as described before
[22]. To promote attachment of single PR molecules, the AFM tip was
pushed on the mica support that has been covered with PR/ND com-
plexes. After applying a force (≈1 nN) for 1 s, theAFM tipwas retracted.
During retraction, the deﬂection of the cantilever was recorded in a
force-distance (F-D) curve. All SMFS experiments were carried out in
buffer solution (10 mM Tris-HCl, 100 mM NaCl, pH 8.0) and at room
temperature as described elsewhere [23].
2.9. Flash photolysis
The absorption changes of the retinal co-factor after photoexcita-
tion was measured at three deﬁned wavelengths and blotted against
the time. Spectral shifts depend on conformational rearrangements of
the retinal binding pocket and are associated with dynamic processes
resulting in the formation of several intermediate enzymatic states.
The detected speciﬁc absorption changes within appropriate time-scales are thus an indication of proper protein folding and give evidence
of the proton pumping potential of PR. The ﬂash photolysis setup was
described in detail earlier [24]. The data points were taken until
980 ms after excitation. The transient data set was analyzed by a global
ﬁt analysis using a sum of exponential decays consisting of equal time
constants for all wavelengths but variable amplitudes (Origin 8.5).
3. Results
3.1. Assembly of NDs with MSP1 and MSP1E3D1 and different lipid
compositions as supplements for CF expression
For each analyzed MSP/lipid combination, a pilot study was ﬁrst
performed by SEC analysis in order to deﬁne optimal ratios of MSP
to lipid for efﬁcient and most homogeneous ND assembly (Fig. A1 A,
Supplementary data). The determined ratios were then further used
for preparative scale preparations (Table A2, Supplementary data).
Stocks could be concentrated up to 1.2 mM and NDs formed with
MSP1 (DMPC) were stable for weeks at +4 °C and even persisted
treatment with 4 M urea at higher temperatures (Fig. A1 B, Supple-
mentary Data). The larger NDs formed with MSP1E3D1 tend to pre-
cipitate already within a few days at +4 °C. In addition, NDs loaded
with unsaturated lipids tend to be less stable. For longer term storage,
ND preparations were therefore frozen in liquid nitrogen and stored
at−80 °C without a loss of integrity. All tested ND samples remained
stable at least for overnight incubation at +30 °C and could thus be
used as additives for CF expression reactions.
MSP1-ND (DMPC) were tolerated by the CF system up to 150 μM
ﬁnal concentration (Fig. A2 A, Supplementary data). Tolerance was
independent from membrane composition and even 100 μM ﬁnal
concentration NDs assembled with anionic lipids such as DOPG did
not shift the highly critical Mg2+ optimum of the CF expression reac-
tion (Fig. A2 B+C, Supplementary data). Added preformed liposomes
often almost quantitatively precipitate during CF reactions presum-
ably due to major rearrangements caused by MP association or inte-
gration [8–13].
In order to analyze the stability and solubility of NDs during CF re-
actions, MSP1-NDs (DMPC) were labeled by including 1% PC-NBD
conjugate during assembly. CF reactions were performed with high
(120 μM) as well as with low (25 μM) concentrations of labeled
NDs and without template DNA, with 3 ng/μl template DNA or with
30 ng/μl template DNA of the multidrug transporter SugE (Fig. A2 D,
Supplementary data). The ND recovery from the RM supernatant
after incubation showed clear correlation with the SugE expression.
Complete ND recovery was obtained without template DNA and
with a high ND to SugE template ratio. Decreasing the ratio by either
increased SugE template or by reduced ND concentration resulted
into ND precipitation presumably by multiple insertion/association
of the synthesized MPs with the provided NDs under non-optimal
stoichiometries.
3.2. Optimizing the co-translational formation of solubleMP/ND complexes
The bacterial light-driven proton pump proteorhodopsin and
C-terminal sGFP-fusions of the two E. coli multidrug transporters
SugE and EmrE, as well as of the E. coli MraY translocase were ana-
lyzed for the co-translational complex formation with supplied
preformed NDs. Either sGFP ﬂuorescence in supernatant and pellet
of the reactions or the speciﬁc absorbance of PR (A530) in its retinal
bound state were quantiﬁed as initial monitor for soluble MP/ND
complex formation containing folded proteins. The impact of the
lipid type on MP/ND complex formation was analyzed with
MSP1-NDs and MSP1E3D1-NDs assembled with DMPC, DOPC or
DOPG.
Generally, the percentage of solubleMP/ND fraction could be titrated
with the initially supplied ND concentration and reached inmost cases a
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complex formation was obtained with PR and SugE-sGFP/EmrE-sGFP
at ND concentrations of approximately 30 μM. A slight lipid preference
for DOPG and DOPC with SugE and for DMPC and DOPG with PR is de-
tectable. Soluble complex formation of EmrE-sGFP was similar to that
of SugE-sGFP (data not shown). The soluble complex formation with
MraY-sGFP was clearly less efﬁcient with only some 30–50% at the
highest analyzed concentration of 120 μMNDs. The expression efﬁcien-
cy of the MPs was quantiﬁed according to calibration curves of puriﬁed
sGFP ﬂuorescence or puriﬁed PR absorption. Highest concentrations in
the supernatant were found with 60 μM for SugE-sGFP in DOPG,
90 μM for PR in DOPC and 44 μM for MraY in DOPG.
The larger MSP1E3D1-NDs increased in most cases the efﬁciency of
soluble MP/ND complex formation (Fig. 1). Almost 100% soluble PR/ND
or SugE-sGFP/ND complex were already obtained with approximately
20 μM NDs. While PR did not show any pronounced lipid preference,
a slower complex formation was monitored with SugE-sGFP andFig. 1. Co-translational and soluble MP/ND complex formation with different lipids. CEC
MSP1-NDs (A, C, E) or MSP1E3D1-NDs (B, D, F). The sGFP ﬂuorescence (SugE-sGFP, MraY
after expression. The sum of both values was set at 100% for each individual ND concentra
the ND concentration. Each data point represents at least three independent determinationDOPC. In contrast, soluble complex formation with MSP1E3D1-ND
(DMPC) was increased if compared with MSP1-ND (DMPC). Most pro-
nounced was the effect of MSP1E3D1-NDs to the soluble complex for-
mation with the translocase MraY-sGFP. While the soluble complex
formation was nearly unchanged with MSP1E3D1-NDs containing
membranes composed of the zwitter‐ionic lipids DMPC and DOPC, the
supply of MSP1E3D1-NDs assembled with the anionic lipid DOPG
resulted in rapid increase of soluble complex formation with nearly
100% solubility at 125 μM ﬁnal ND concentration (Fig. 1). Quantiﬁcation
of the soluble complexes at best conditions were 106 μM for PR in
DOPG, 63 μM for SugE-sGFP in DOPG and 67 μM for MraY in DOPG.
The soluble MP/ND complexes were puriﬁed by taking advantage of
the C-terminal StrepII-tags of the MPs and analyzed by SDS-PAGE
(Fig. 2). The estimated yields out of 1 ml RM were 0.49 mg for EmrE/
MSP1-NDs (DMPC), 0.98 mg for EmrE/MSP1E3D1-NDs (DMPC),
2.04 mg for PR/MSP1-NDs (DMPC), 3.05 mg for PR/MSP1E3D1-NDs
(DMPC), and 1.87 mg for MraY-sGFP/MSP1E3D1-NDs (DMPG).F expression of SugE-sGFP (A+B), PR (C+D) and MraY-sGFP (E+F) with supplied
-sGFP) or A530 absorbance (PR) was measured in the soluble and insoluble fractions
tion and target. The relative signal intensity of the soluble fractions is blotted against
s.
Fig. 2. Puriﬁcation of co-translationally formed soluble MP/ND complexes. The super-
natants of preparative scale CECF reactions in the presence of empty NDs were afﬁnity
puriﬁed via StrepII-Tactin, analyzed by SDS-PAGE (11% (w/v) Tris/Tricine) and stained
with Coomassie blue. Lane 1, puriﬁed MSP1; Lane 2, puriﬁed MSP1E3D1; Lane 3,
non-puriﬁed RM supernatant of EmrE/MSP1-ND (DMPC) reaction; Lane 4, puriﬁed
EmrE/MSP1-ND (DMPC); Lane 5, puriﬁed PR/MSP1-ND (DMPC); Lane 6, non-puriﬁed
RM supernatant of EmrE/MSP1E3D1-ND (DMPC); Lane 7, puriﬁed EmrE/MSP1E3D1-ND
(DMPC); Lane 8, puriﬁed PR/MSP1E3D1-ND (DMPC); Lane 9, puriﬁed MraY-sGFP/
MSP1E3D1-ND (DMPG); M, marker proteins.
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The enzymatic activity of E. coli MraY translocase depends on the
presence of lipids [7]. CF expression of MraY in the presence of deter-
gents only results in inactive and aggregated protein. The identiﬁca-
tion of speciﬁc lipid requirements for the functional folding of MraY
was therefore analyzed with soluble MraY-sGFP/ND complexes puri-
ﬁed after CF expression in the presence of 120 μM NDs assembled
with different lipids. Final sample concentrations were determined
after StrepII-tag afﬁnity puriﬁcation by quantiﬁcation of either sGFP
ﬂuorescence or immunoblotting.
NDs composed of MSP1 or MSP1E3D1 and either assembled with
zwitter-ionic phosphocholine (PC) or phosphoethanol-amine (PE)
derivatives, with anionic phosphoglycerol (PG) derivatives or with
complex lipid mixtures isolated from E. coli membranes have been
analyzed (Table 1). Highest soluble MraY-sGFP/ND complex forma-
tion of >90% was obtained with the anionic lipids DMPG or DOPG
and with MSP1E3D1-NDs. The similar yields indicate that chain
length or saturation degree of the alkyl side-chain of the two lipids
do not play a critical role in soluble complex formation. Lower
amounts of soluble complexes with MSP1E3D1-NDs were formed
with the lipids DMPC, POPC and DOPC, but yields were still sufﬁcient
for subsequent functional analysis. Almost no soluble MraY-sGFP/ND
complexes were detectable using DOPE. Recovery of the MraY-sGFP/Table 1
Functional analysis of puriﬁed MraY-sGFP/ND complexes.
MSP1-ND
Lipid Solubilitya Afﬁnity Activit
[%] Puriﬁcationc [nmol/
DMPC 27.3 + 0
POPC n.a.d n.a.d n.a.d
DOPC 27.2 + 0
DMPG n.a.d n.a.d n.a.d
DMPG/Cde n.a.d n.a.d n.a.d
POPG n.a.d n.a.d n.a.d
DOPG 34.6 ++ 3.3
DOPE n.a.d n.a.d n.a.d
PL 4.0 ± n.a.d
TL n.a.d n.a.d n.a.d
a Overall solubility of MraY-sGFP/ND complex after expression.
b Speciﬁc activity in nmol lipid I/μg MraY.
c Concentration in main elution fraction: ±, b0.01 mg/ml; +, 0.01–0.1 mg/ml; ++, >0.
d Not accomplished, either experiments not performed, or puriﬁcation not successful.
e DMPG lipids supplied with 10% (mol/mol) cardiolipin (Cd, 14:0).ND complexes after StrepII-tag afﬁnity puriﬁcation mostly correlated
with the initial yields in the RMs. Exceptions were MraY-sGFP
expressed in the presence of MSP1E3D1-NDs (PL) and MSP1E3D1-
NDs (TL). Despite detectable soluble complex formation, weak bind-
ing to the afﬁnity matrix prevented recovery of samples sufﬁcient
for functional analysis.
Speciﬁc enzymatic activity of 500 ng aliquots of puriﬁed MraY-
sGFP/ND samples was analyzed in vitro following lipid I synthesis in
the presence of 5 nmol C55-P and 50 nmol of UDP-MurNAc-
pentapeptide as substrates. The lipid I formation was correlated to the
presence of PG derivatives in the MraY-sGFP/ND complexes (Table 1).
Complexes containingmembranes composed of zwitter‐ionic PC deriv-
atives and with different acyl chains were inactive in lipid I formation,
giving evidence that the functional folding of MraY primarily depends
on the head group chemistry of the lipid. The three- to seven-fold in-
creased speciﬁc activity in lipid I formation with MSP1E3D1-NDs
(DMPG) if compared with MSP1E3D1-NDs assembled with either
DOPG or POPG containing the longer palmitoyl- and/or the unsaturated
oleoyl-chain indicates additional impacts of the bilayer ﬂuidness and/or
thickness on the functional folding of MraY. It is noteworthy that the
speciﬁc activities of MraY-sGFP complexed with either the larger
MSP1E3D1-NDs (DOPG) or with the smaller MSP1-NDs (DOPG) were
comparable (Table 1). The presence of 10% (mol/mol) cardiolipin in
DMPG membranes slightly decreased the MraY-sGFP speciﬁc activity
as well as its efﬁciency in soluble complex formation if compared with
MSP1E3D1-NDs containing pure DMPG membranes (Table 1).
The MraY protein without C-terminal sGFP fusion was furthermore
analyzed for enzymatic activity in MSP1E3D1-NDs (DMPG). Calcula-
tions of the speciﬁc activities of MraY/MSP1E3D1-ND (DMPG) com-
plexes as well as of MraY-sGFP/MSP1E3D1-ND (DMPG) complexes in
this experiment were based on the total protein concentrations of the
puriﬁed samples as analyzed by the Bradford assay and determined to
2.3 nmol/μg of MraY and to 2.5 nmol/μg of MraY-sGFP. Effects of the
sGFP fusion on the speciﬁc activity of MraY are therefore not obvious.
3.4. PR reconstitutes in native conformation into nanodiscs
It remains often unclear whether MPs are inserted or only some-
how associated with NDs. SMFS can characterize individual unfolding
steps that form the unfolding pathway of single MPs [23,25]. The
unfolding pattern recorded by SMFS is sensitive to misfolding of the
MP [25] and, thus, SMFS can give evidence whether MPs properly re-
constitute or simply attach to NDs. In the following we applied SMFS
to characterize the unfolding pattern of PR reconstituted post- or
co-translationally into MSP1-ND (DMPC) (Fig. 3). F-D curves
recorded from the mechanical unfolding of single PRs showed aMSP1E3D1-ND
yb Solubilitya Afﬁnity Activityb
μg] [%] Puriﬁcationc [nmol/μg]
30.4 + 0
19.7 + 0
13.5 + 0
92.5 ++ 9.8
72.6 ++ 8.8
93.4 + 1.4
90.9 + 3.04
2.9 ± n.a.d
27.6 ± n.a.d
12.3 ± n.a.d
1 mg/ml.
Fig. 3. Mechanical unfolding of PR/MSP1-ND (DMPC) complexes by SMFS. Representative force-distance (F-D) curves of PR that have been either post-translationally (A) or
co-translationally (B) reconstituted into MSP1-NDs (DMPC). Each force peak of every F-D curve detects an unfolding event of a single PR molecule. All unfolding events of a F-D
curve describe the unfolding pathway the PR molecule has taken. Superimposition of 100 F-D curves recorded during unfolding of post-translationally (C) and co-translationally
(D) assembled PR/ND complexes. Black lines represent WLC curves used to ﬁt the four major force peaks [23]. Gray scale bars allow statistical interpretation of the gray values
of the superimpositions.
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superimposition of 100 F-D curves recorded from post- or co-
translationally reconstituted PR showed a very similar unfolding pat-
tern. This suggests that PR in both cases had the same fold. The
unfolding pattern of PR reconstituted into NDs was similar to that
recorded of the structurally homologous and functionally active bac-
teriorhodopsin (BR) either post-translationally reconstituted into
NDs or derived from native bacterial purple membranes [22]. More-
over, the unfolding pattern of PR in NDs was very similar to the
unfolding pattern recorded from functionally active PR reconstituted
into DOPC bilayers [26]. This agreement between the PR unfoldingFig. 4. Flash photolysis measurements of co-translationally assembled PR/ND complexes. So
sion. Time resolved absorbance changes were measured for three wavelengths (λ=590 n
MSP1-NDs (DMPC); B, PR/MSP1E3D1-NDs (DMPC).patterns suggests the same functionally active fold in the different
lipid environments.
Time resolved absorption spectroscopy of PR/ND complexes using
ﬂash photolysis was furthermore performed in order to verify the activity
of PR. For both co-translationally assembled PR/ND complexes [MSP1-ND
(DMPC) andMSP1E3D1-ND (DMPC)] a pHdependent shift of the absorp-
tion maximum was observed and attributed to the protonation state of
the primary proton acceptor Asp97. From titration experiments in a
range of pH 5.0 to pH 9.5, the pKa value of Asp97 was calculated as 6.7
for MSP1E3D1-NDs (DMPC) and 6.0 for MSP1-NDs (DMPC) (data not
shown).luble complexes were StrepII-tag afﬁnity puriﬁed after preparative scale CECF expres-
m, λ=500 nm and λ=400 nm) and blotted logarithmically against the time. A, PR/
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changes at three distinct wavelengths at pH 9.0 for co-translationally
inserted PR in MSP1-NDs (DMPC) and in MSP1E3D1-NDs (DMPC)
(Fig. 4). The retinal co-factor exhibits a high spectral sensitivity towards
its environment. Therefore the process of proton pumping can be ob-
served by monitoring the transient absorption changes since this pro-
cess is accompanied by large conformational changes of the protein.
After photoexcitation a series of thermally driven reaction intermedi-
ates occurs, termed K, M, N and O state [27]. For both ND species a de-
crease of absorption at λ=590 nm can be observed on early delay
time which is attributed to the decay of the K-intermediate. This
decay is associated with a rise of the M-intermediate monitored at
λ=400 nm. The decay of the M-intermediate itself is connected with
the formation of the N- and O-intermediates which are observed at
λ=590 nm on longer delay times. Concomitant with the decay of
these species, the ground state bleaching suggests that the whole
photocycle is completed within a second. The high similarity of the
transient absorption changes and the received time constants obtained
from global ﬁt analysis compared to already published data using DDM
solubilized PR [28–30] as well as of PR post-translationally assembled
into NDs [27] indicates identical conformations of PR in the analyzed
co-translationally assembled PR/ND complexes. Only the lifetime of
the M-intermediates is considerably increased in NDs compared to de-
tergent solubilized wild type PR reported earlier.
4. Discussion
NDs are about to become a new standard in MP research and
biochemical as well as biophysical applications are rapidly increas-
ing [31,32]. However, most studies were performed with post-
translationally formed complexes obtainedwith classical reconstitution
approaches using detergent solubilized MPs. The co-translational asso-
ciation of nascentMPswith pre-formed emptyNDs by taking advantage
of CF expression systems has only recently been addressed [15–17]. By
this strategy, any detergent contacts of theMPs are avoided and speciﬁc
lipid requirements can systematically be analyzed.
The NDs were tolerated by the CF system up to ﬁnal concentration
of 100 μM, with some minor decrease of expression yields at ﬁnal
concentrations of 150 μM with at least MSP1-NDs containing the
zwitter-ionic lipid DMPC. Liposomes composed of the anionic lipid
POPG were found to be slightly inhibitory to CF reactions at higher
concentrations as well [33]. If ND concentrations in between 100
and 150 μM deﬁne some upper limit in CF reactions, this would
already correspond to the relatively high lipid concentration of ap-
proximately 10–16 mg/ml RM. The addition of liposomes as small
uni-lamellar vesicles (SUV) to CF reactions becomes limiting at simi-
lar ﬁnal lipid concentrations of approximately 9–12 mg/ml RM. How-
ever, while access for MP insertion into vesicles is conﬁned to only
one side of the membrane, the two-sided access to the membranes
in NDs doubles the chance of insertion or association events. Consid-
ering the theoretically accessible membrane, the calculated area of
approximately 6.67 m2/ml RM at 150 μMMSP1-NDs resembles close-
ly the in vivo situation [34].
MP-sGFP fusions were shown to be useful for protocol develop-
ment of co-translational MP/ND complex formation which is in accor-
dance with their already documented applications of expression
monitoring in vivo [35–37]. Quantiﬁcation by sGFP ﬂuorescence
might further be valuable for ﬁrst approximations of the MP stoichi-
ometry in complexes with NDs. Multiple association of MPs or associ-
ation of MP oligomers with in particular the larger MSP1E3D1-NDs is
very likely. Dimer as well as unspeciﬁc trimer formation of the
co-translational inserted transmembrane domain of the human re-
ceptor tyrosine kinase ErbB3 is already one reported example [17].
Considering the stoichiometries of MP and ND concentrations at
highest soluble complex formation, strong evidence for multimeric
association of PR and SugE is given. At approximately 25 μMMSP1E3D1-NDs with DMPC or DOPG a concentration of soluble
SugE-sGFP of 56 μM and 63 μMwas detected, giving a ratio of roughly
1 to 2. Accordingly, the dimer formation of the homolog EmrE has
been observed before [38]. For PR, approximately 100 μM protein is
solubilized with 15 to 20 μM MSP1E3D1-NDs which is in agreement
with proposed hexamer and pentamer formations [26]. However, fur-
ther complementary assays are needed in order to conﬁrm these pre-
liminary evidences.
Key parameters for the efﬁciency of soluble MP/ND complex for-
mation are MSP species, ND concentration and membrane composi-
tion. Membranes composed of the anionic lipid DOPG overall
increased soluble complex formation with both ND types and with
all analyzed MPs. Increasing membrane ﬂuidity by replacing DMPC
with DOPC was rather negative for MP/ND complex formation. The
larger MSP1E3D1-NDs appear to be clearly more efﬁcient to accom-
modate larger MPs such as the ten TMS containing MraY. However,
the number of TMSs is obviously not an exclusive determinant of suc-
cessful MP/ND complex formation as the ND association of PR with
seven TMS were even better if compared with SugE having only
four TMS. All MPs had high CF expression levels ensuring that the
MPs are not limiting for the analyzed complex formations.
At suboptimal concentrations, a fraction of the supplied NDs ag-
gregates and precipitates. Fluorescent MP-sGFP fusions as well as
the detection of the speciﬁc A530 absorbance of PR indicated that
some of the co-precipitated MPs are associated with the NDs and po-
tentially folded (data not shown). ND aggregation might be caused by
incomplete insertion of MPs as a result of ND limitation. Partial inser-
tion into multiple NDs or intermolecular aggregation after unfolding
could induce the observed ND clustering. Increasing ND concentra-
tions resulted in more soluble complex formation of ErbB3, of the
voltage-sensing domain of K+ channel KvAP (VSD) and of bacterio-
rhodopsin [17]. However no inﬂuence of the selected membrane
compositions could be detected.
MP insertion into NDs is difﬁcult to study and functionality can be
considered at least a strong indication. SMFS studies with MP/ND
complexes are feasible as a complementary or alternative approach
[22]. With post-translationally assembled BR/ND complexes, similar
unfolding pathways were obtained if compared with those of BR in
natural bacterial purple membranes. Comparing unfolding pathways
of post- and co-translationally assembled PR/MSP1-ND (DMPC)
complexes with the data recorded from PR reconstituted into DOPC
liposomes, indicate the complete insertion of PR for the co-
translationally formed PR/ND complexes. The generation of func-
tional PR within the lipid membrane of NDs is further supported by
ﬂash photolysis. The determined pKa values are slightly shifted to
more acidic values if compared with previously described data,
which is most likely attributed to different buffer conditions [27].
Analysis of time-resolved absorbance changes at pH 9.0 indicates
that the co-translationally inserted PR undergoes all phases of the
photocycle including the generation and disintegration of the
M-intermediate, although the lifetime of the M-intermediate is
slightly increased for PR embedded in NDs. These ﬁndings point to
a retarded reprotonation of the Schiff base, whereas we do not see
signiﬁcant differences in other photocycle steps and for the de-
scribed ND-species.
Lipids can act as folding chaperones and are often essential for MP
structure, stability and function [39–43]. Main components of the
E. coli cytoplasmic membrane are (w/w) PE (70–80%), PG (15–20%)
and cardiolipin (5%), while composition of the fatty acid moieties fur-
ther depends on the bacterial growth phase [44,45]. We could show
for the ﬁrst time that the E. coli translocase MraY acquires its func-
tional folding when associated with uniform bilayers composed of
lipids containing anionic head groups. This result agrees with previ-
ous ﬁndings that E. coli MraY could be obtained only in functional
and folded condition if CF is expressed in the presence of SUVs,
while its contact with detergents either co- or post-translationally
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pendent activity of E. coli MraY was also observed in samples
obtained from native membranes [46]. Lipids appear to play impor-
tant roles in the stabilization and/or folding of other MraY homologs.
Membrane extracted and detergent solubilized MraY proteins of
Staphylococcus aureus and of Micrococcus luteus could be reactivated
to some extent by the addition of lipids [47,48]. However, the func-
tion of Bacillus subtilis MraY was independent from lipids and high
activity has been obtained after solubilization in detergent [7]. Lipid
charge was of prime importance for E. coli MraY function and the na-
ture of the fatty acid moiety further contribute to its speciﬁc activity.
Since solubility of MraY/NDs composed of either DMPG or DOPG was
similar, the three-fold higher speciﬁc activity with DMPG could result
either from higher turnover numbers or from reduced amounts of
functional MraY in the NDs (DOPG). ND complexes with MraY and
DMPC did not result into active protein. The rather linear and
non-saturable association kinetics of MraY with NDs containing
membranes out of phosphocholines already gave evidence that stabi-
lization, folding or insertion mechanisms with this lipid type present
in eukaryotic membranes could be different if compared with DOPG.
In contrast, general insertion problems are obviously the major rea-
son for the failure to obtain soluble MraY/MSP1E3D1-ND complexes
containing membranes out of DOPE, the major lipid of E. coli inner
membranes. It should further be noted that only approximately 12%
of the NDs assembled with E. coli total lipid extracts formed soluble com-
plexes with MraY, while the failure to efﬁciently access the StrepII-tag by
the afﬁnity matrix also indicated structural rearrangements of the MraY
protein.5. Conclusions
The protocol development for the co-translational formation of
soluble MP/ND complexes has been improved by deﬁning optimal
MSP to lipid ratios for ND assembly, by implementing MP-GFP fusions
for quantitative monitoring and by using a differential tag puriﬁcation
strategy. NDs assembled with the larger MSP1E3D1 derivative appear
generally more efﬁcient in particular for the formation of soluble
complexes with CF expressed MPs containing increased numbers of
TMSs. Strong evidence for the co-translational integration of PR into
ND membranes has been obtained by SMFS and photocycle measure-
ment. We further demonstrate that the composition of the ND mem-
brane can be highly critical for the formation of soluble MP/ND
complexes as well as for the functional folding of the associated
MPs. MraY/ND complexes with DMPCwere not active in lipid I forma-
tion and the MraY functionality was shown to depend on lipid head
group chemistry with some further impacts of the degree of lipid sat-
uration. This experimental setup provides rapid access to a variety of
MP samples and allows the study of their functional and structural
characteristics in deﬁned membrane environments without exposure
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